Penn Researchers Uncover Novel Immune Therapy for Pancreatic Cancer

PHILADELPHIA - Researchers at the University of Pennsylvania's Abramson Cancer Center have discovered a novel way of treating pancreatic cancer by activating the immune system to destroy the cancer's scaffolding. The strategy was tested in a small cohort of patients with advanced pancreatic cancer, several of whose tumors shrank substantially. The team believes their findings - and the novel way in which they uncovered them -- could lead to quicker, less expensive cancer drug development.
more

More AFCRI news

---

Stay Connected to AFCRI

AFCRI NEWS

twitter	Youtube	facebook

---

EVENTS

Abramson Family Cancer Research Institute Events

 

Learn more

RESEARCH AREAS AND STUDY PROGRAMS

RESEARCH AREAS

• Cancer Cell Biology
• Signal Transduction
• Translational Research
• Cancer Genetics
• Cancer Prevention
• Clinical Trials

  RESEARCH PROGRAMS

• Graduate, Grad-Medical, Postdoctoral, Undergraduate info

   

 

VIDEOS FEATURING OUR RESEARCH TEAM

 

---

Genetically Modified "Serial Killer" T Cells Obliterate Tumors in Patients with Chronic Lymphocytic Leukemia, Penn Researchers Report

Penn Researchers Uncover Novel Immune Therapy for Pancreatic Cancer

Drug Stimulates Immune System to Attack "Scaffolding" Around Tumors

---

Personalized Medicine - Your Life is Worth Penn Medicine

Promotional video featuring the Abramson Cancer Center